Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

 

 

Skin-Melanocytic tumors

Hyperpigmentation

 

Author: Nat Pernick, M.D., PathologyOutlines.com, Inc.

Revised: 5 July 2009, last major update November 2008

Copyright: (c) 2005-2009, PathologyOutlines.com, Inc.

 

Clinical

=========================================================================

● Common, usually harmless condition, in which patches of skin become darker than normal surrounding skin

● Due to melanocyte stimulation from sunlight, heat, post-inflammatory (eMedicine), drugs (Merck), hormones, malignancy, metabolic disease, scars, various dermatoses, familial progressive hyperpigmentation (Eur J Dermatol 2006;16:246)

● Patches near axilla may be post-inflammatory due to hair plucking (Int J Cosmet Sci 2006;28:247)

Amiodarone may deposit in skin and cause hyperpigmentation (Arch Dermatol 2008;144:92)

Hyperpigmentation can be evaluated with Taylor hyperpigmentation scale (Cutis 2005;76:270)

Age / liver spots are common, due to sun damage on hands or face

 

Case reports

=========================================================================

Drugs

● Bleomycin (Arch Dermatol 2003;139:337)

● Diltiazem (Arch Dermatol 2006;142:206)

● Hydroxychloroquine (J Cutan Pathol 2008;35:1134)

Imatinib (Dermatol Online J 2008;14(7):7)

Imipramine (Dermatol Online J 2007;13(4):8)

Minocycline (J Clin Rheumatol 2008;14:17)

 

Malignancy

Leukemia cutis (J Cutan Pathol 2008;35:662)

 

Other

Periungual hyperpigmentation in newborns (Pediatr Dermatol 2008;25:25)

Vitamin B12 deficiency (Indian J Dermatol Venereol Leprol 2006;72:389)

 

Treatment

=========================================================================

● None

● Bleaching products with hydroquinone, retinol and antioxidants (Cutis 2008;81:365)

Laser therapy (Plast Reconstr Surg 2008;121:282)

Note: hydroquinone slows production of melanin so darker areas gradually fade to match surrounding skin; tretinoin and cortisone take 3-6 months to produce improvement

 

Clinical description

=========================================================================

Skin with darker pigmentation than surrounding healthy skin, due to increased melanin

 

Clinical images

=========================================================================

 

Post-drug use:

                                   

Bleomycin                            Diltiazem                               Imatinib                

 

 

            

Imipramine                           Minocycline                                                                         

 

 

Other:

Pre- and post-treatment for Vitamin B12 deficiency

 

 

Post-inflammatory arthritis

 

Micro description

=========================================================================

● Increased pigmentation of basal keratinocytes, increased transfer of melanin into adjacent keratinocytes

● Variable melanophages, deposits in dermal cells and apoptotic cells

● No atypia

 

Micro images

=========================================================================

 

                                         

Diltiazem                                                               Imipramine: gold brown pigment in upper and mid dermis

 

Additional references

=========================================================================

Wikipedia

 

End of Skin-Melanocytic Tumors > Hyperpigmentation

 

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.